Topic: Takeda Pharmaceutical Co. Ltd.
LONDON (Reuters) - A clinical trial testing an experimental GlaxoSmithKline drug that mimics a health-boosting compound found in red wine has been suspended due to safety issues.A company spokeswoman said on Tuesday that the trial of SRT501 in patients wi
Company to be acquired by Takeda Pharmaceutical CompanyShares of California-based IDM Pharma (NASDAQ: IDMI, Stock Forum) soared 53.5% to $2.61 Monday, after the company announced that Japan’s Takeda Pharmaceutical Company’s subsidiary, Takeda America Hold
